| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 445.64 KB | Adobe PDF |
Orientador(es)
Resumo(s)
The late and incomplete penetrance that characterizes hypertrophic cardiomyopathy (HCM), combined with the relatively low – 40–50% – yield of genetic testing, has stimulated the search for markers of early disease in “pre-hypertrophic” relatives of index patients. The main suggested aims of those markers are to identify relatives at risk of developing HCM in families where a causal mutation is not identified, or to predict the risk of developing disease in carriers of a causal mutation in a non-hypertrophic stage. The clinical value of identifying
these markers remains to be validated. We describe a possible novel and clinical relevant marker of this
subclinical/pre-hypertrophic stage, as we report two pathogenic mutation carriers without hypertrophy, where a significant latent left ventricular outflow tract (LVOT) gradient was identified by treadmill stress echocardiography.
Descrição
© 2014 Elsevier Ireland Ltd. All rights reserved.
Palavras-chave
Exercise stress echocardiography Genetics Hypertrophic cardiomyopathy Left ventricular outflow tract obstruction Mutation carriers
Contexto Educativo
Citação
Int J Cardiol. 2014 Oct 20;176(3):1264-1267
Editora
Elsevier
